Bluejay Diagnostics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Bluejay Diagnostics, Inc. (BJDX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $180.34 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-20
- Bluejay Diagnostics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-03-31 was $180.34K.
- Bluejay Diagnostics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $180.34K, a 0.00% change from fiscal 2021.
- Bluejay Diagnostics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $180.34K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2022-12-31 | $180.34K 10-K · filed 2023-03-20 | |
| 2021-12-31 | $180.34K 10-K · filed 2022-03-10 | |
| 2021-03-31 | $180.34K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |